In this week’s Scientist Highlights, we feature Chao Cai, PhD, who became a CCADMR Scientist in 2021. Dr. Cai’s RCMAR pilot project is “Evaluate Effects of Determinants on Diagnosis of ADRD Using Novel Statistical Cure Model”. Dr. Cai’s areas of expertise include applying advanced statistical methods in outcomes sciences and providing statistical consulting in collaborative research.

Check out Dr. Chao’s Twitter poster presentation at this year’s RCMAR Annual Meeting “Evaluate Effects of Determinants on Diagnosis of ADRD using Novel Statistical Cure Model”.

View her 2 most recent publications:

1. Estimated Cost-effectiveness of Atezolizumab Plus Cobimetinib and Vemurafenib for Treatment of BRAF V600 Variation Metastatic Melanoma
   • This work was presented at ISPOR (professional society for health economics and outcomes research) 2022 Annual Conference and she was chosen as Research Presentation Award Finalist.
   • Read Dr. Chao’s interview with Reuters Health Information.
2. Applying Mixture Cure Survival Modeling to Medication Persistence Analysis
   • This paper introduced cure model framework in studying effects of variables associated with medication persistence in Pharmacoepidemiology study.

Learn more about Dr. Cai.

Visit the CCADMR website.